Literature DB >> 28656589

The prognostic value of a trend in modified SOFA score for patients with hematological malignancies in the intensive care unit.

Astrid M P Demandt1, Daniël A Geerse2, Bram J P Janssen3, Bjorn Winkens4, Harry C Schouten1, Walther N K A van Mook5.   

Abstract

BACKGROUND: Patients with hematological malignancies admitted to an intensive care unit (ICU) have a poor prognosis. The Sequential Organ Failure Assessment (SOFA) score is used to monitor patients on the ICU. Little is known about the value of this score in hematology patients. Therefore, the prognostic value of the SOFA score and a modified hematological SOFA score (SOFAhem) was studied.
METHODS: Patients with hematological malignancies admitted to the ICU between 1999 and 2009 were analyzed in a retrospective cohort study. The SOFAhem score was defined as the original SOFA score omitting the coagulation and neurological parameters.
RESULTS: In 149 admissions, ICU mortality was 52%. Mortality was significantly associated with higher SOFA and SOFAhem scores on admission, and trend in SOFAhem scores. An unchanged and increased SOFAhem score compared to decreasing SOFAhem scores was associated with a higher mortality rate (53% resp 67% resp 25%).
CONCLUSIONS: Trends in SOFA or SOFAhem score are both suitable as prognostic parameter. The trend in SOFAhem score seems to be independently related to mortality in hematological patients admitted to the ICU, and because of the higher odds ratios and lower P-values compared to the SOFA score, it is probably stronger related to mortality than the classical score, but its prognostic value should be tested in a larger cohort.
© 2017 The Authors. European Journal of Haematology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hematological; intensive care; prognosis; sequential organ failure assessment

Mesh:

Year:  2017        PMID: 28656589     DOI: 10.1111/ejh.12919

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study.

Authors:  Zheng Yang; Qinming Hu; Fei Huang; Shouxin Xiong; Yi Sun
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

2.  SOFA Score Plus Impedance Ratio Predicts Mortality in Critically Ill Patients Admitted to the Emergency Department: Retrospective Observational Study.

Authors:  Ashuin Kammar-García; Lilia Castillo-Martínez; Javier Mancilla-Galindo; José Luis Villanueva-Juárez; Anayeli Pérez-Pérez; Héctor Isaac Rocha-González; Jesús Arrieta-Valencia; Miguel Remolina-Schlig; Thierry Hernández-Gilsoul
Journal:  Healthcare (Basel)       Date:  2022-04-27

3.  Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter study.

Authors:  Lucie Probst; Enrico Schalk; Tobias Liebregts; Vanja Zeremski; Asterios Tzalavras; Michael von Bergwelt-Baildon; Nina Hesse; Johanna Prinz; Jörg Janne Vehreschild; Alexander Shimabukuro-Vornhagen; Dennis A Eichenauer; Jorge Garcia Borrega; Matthias Kochanek; Boris Böll
Journal:  J Intensive Care       Date:  2019-08-07

Review 4.  The SOFA score-development, utility and challenges of accurate assessment in clinical trials.

Authors:  Simon Lambden; Pierre Francois Laterre; Mitchell M Levy; Bruno Francois
Journal:  Crit Care       Date:  2019-11-27       Impact factor: 9.097

5.  SOFA score is superior to APACHE-II score in predicting the prognosis of critically ill patients with acute kidney injury undergoing continuous renal replacement therapy.

Authors:  Hai Wang; Xiao Kang; Yu Shi; Zheng-Hai Bai; Jun-Hua Lv; Jiang-Li Sun; Hong Hong Pei
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

6.  The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients.

Authors:  Pungkava Sricharoen; Chaithawat Chueluecha; Chaiyaporn Yuksen; Chetsadakon Jenpanitpong
Journal:  Open Access Emerg Med       Date:  2022-02-05

7.  Comparison of a modified Sequential Organ Failure Assessment Score using RASS and FOUR.

Authors:  Gabriel Piñeiro Telles; Isabella Bonifácio Brige Ferreira; Rodrigo Carvalho de Menezes; Thomas Azevedo do Carmo; Paula Lins David Pugas; Lara Freitas Marback; Maria B Arriaga; Kiyoshi F Fukutani; Licurgo Pamplona Neto; Sydney Agareno; Kevan M Akrami; Nivaldo Menezes Filgueiras Filho; Bruno B Andrade
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

8.  Outcomes and Risk Factors of Critically Ill Patients with Hematological Malignancy. Prospective Single-Centre Observational Study.

Authors:  Šarūnas Judickas; Raimundas Stasiūnaitis; Andrius Žučenka; Tadas Žvirblis; Mindaugas Šerpytis; Jūratė Šipylaitė
Journal:  Medicina (Kaunas)       Date:  2021-11-30       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.